Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03464838
Other study ID # UREC 1718 23
Secondary ID 241677
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date March 6, 2019
Est. completion date September 1, 2020

Study information

Verified date April 2019
Source University of East London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gambling disorder is associated to high impulsivity and excessive risk-taking behaviour. These behavioural characteristics related to addiction are linked to cognitive processes in specific brain areas located in the prefrontal cortex (PFC).

With the aim of studying the role of PFC in gambling disorder, the investigators employ transcranial current direct stimulation (tDCS), a noninvasive brain stimulation technique that applies a very weak electrical current to the superficial areas of the brain.

The clinical phase of the research consists on studying the effects of tDCS in combination with cognitive behavioural therapy (CBT) in patients that attend the United Kingdom (UK) National Problem Gambling Clinic. The main objective of the project is to investigate whether the combination of tDCS and CBT can help to decrease impulsivity and risk-taking behaviour and therefore improve the treatment for gambling disorder.


Description:

The investigators aim to have a total of 32 participants diagnosed with gambling disorder with the Problem Gambling Severity Index (PGSI). There will be 16 participants per group having two different groups (real stimulation and sham). Real stimulation involves the application of tDCS stimulation and sham condition is used as a control (similar to a placebo).

Participants will attend 8 weekly sessions where they receive tDCS stimulation for 20 minutes, while complete CANTAB cognitive tasks that measure cognitive processes such us control inhibition and risk-taking behaviour. Electroencephalography (EEG) activity will be measured before and after tDCS.

Participants will also complete cognitive questionnaires (Pathological Gambling adapted Yale-Brown Obsessive Compulsive Scale (PG-YBOCS), Gambling Symptom Assessment Scale (G-SAS) and Visual Analogue Scale (VAS) for gambling cravings.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 32
Est. completion date September 1, 2020
Est. primary completion date April 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Male or females between 18-65 years old diagnosed with disordered gambling based on the Problem Gambling Severity Index (PGSI) who can speak and read English and don't have any of the exclusion criteria.

Exclusion Criteria:

1. History or evidence of chronic or residual neurological disease.

2. A pacemaker or deep brain stimulation.

3. Metal implants in head or neck area (e.g. postoperative clips after intracerebral aneurysm; arterial aneurysm in the vascular system, implantation of an artificial hearing aid).

4. Intracerebral ischemia/history of bleeding.

5. Prior evidence of epileptic seizures, history of epilepsy.

6. History of head injury with loss of consciousness.

7. Any serious medical conditions (disease of the internal organs).

8. Pregnancy or breast-feeding.

9. Negative prescreening from the clinic psychiatrist.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcranial direct current stimulation (tDCS)
Transcranial direct current stimulation (tDCS) is a form of noninvasive brain stimulation that applies a very low electrical current to the scalp. tDCS will be applied with intensity of 1.8 milliamps in real stimulation condition and 0 milliamps in sham condition, during 20 minutes, using a high density (HD) tDCS montage over the Prefrontal Cortex (PFC). Electroencephalography (EEG) resting state activity will be measured before and after tDCS.
Behavioral:
Cognitive Behavioural Therapy (CBT)
Cognitive Behavioural Therapy (CBT) is the current treatment available for disordered gamblers at the UK National Problem Gambling Clinic. During the therapy sessions patients acquire learning strategies, cognitive and motivational elements, and develop personal skills to help them improve the understanding of their problems.

Locations

Country Name City State
United Kingdom University of East London London

Sponsors (3)

Lead Sponsor Collaborator
University of East London GambleAware, National Problem Gambling Clinic

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in scores on the Yale-Brown Obsessive Compulsive Scale adapted for Pathological Gambling (PG-YBOCS) It is a 10-item questionnaire that measures the gambling severity. The scores range from 0 to 4 in each question and the total score ranges from 0 to 40. The questions 1 to 5 assess urges and thoughts associated with gambling disorder, and the rest assess the behavioral component of the disorder. The total score will be calculated as well as the separate scores. Gambling severity will be higher with higher PG-YBOCS scores. Change from baseline PG-YBOCS scores at week 2, 3, 4, 5, 6, 7 and 8
Primary Change in scores on the Visual Analogue Scale (VAS) It is a horizontal line which length is 100 mm where the left side corresponds to the lower scores and the right side to the highest scores (it ranges from 0 to 10). The participant will draw a line where the level best represents their gambling cravings at the current time. The score will be calculated by measuring this line (in millimetres). The gambling cravings will be higher with higher VAS scores. Change from baseline VAS scores at week 2, 3, 4, 5, 6, 7 and 8
Primary Change in scores on the Gambling Symptom Assessment Scale (G-SAS) It is a 12-item scale to measure gambling symptoms. Each of the 12 questions has a score ranging from 0 to 4 based on the last week. It is useful to measure changes during treatment. The total score ranges from 0 to 48. The symptoms severity will be higher with higher G-SAS scores. Change from baseline G-SAS scores at week 8
Primary Change in scores on the Cambridge Gambling Task (CGT) Measures of gambling behaviour. Change from baseline CGT scores at week 8
Secondary Change in scores on the Information Sampling Task (IST) Measures of impulsivity Change from baseline IST scores at week 2, 3, 4, 5, 6, 7 and 8
Secondary Change in scores on the Stop Signal Task (SST) Measures of control inhibition Change from baseline IST scores at week 2, 3, 4, 5, 6, 7 and 8
Secondary Change in encephalography (EEG) activity Measures of endogenous oscillatory neural activity Change from baseline EEG activity in weeks 1, 2, 3, 4, 5, 6, 7 and 8
See also
  Status Clinical Trial Phase
Completed NCT02590211 - Poker, Skills and Associated Problems N/A
Completed NCT02203786 - D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement Phase 2
Completed NCT05051085 - Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling N/A
Completed NCT01215357 - Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble Phase 2
Terminated NCT00245583 - Topiramate in the Treatment of Pathological Gambling Phase 3
Completed NCT04842461 - Mental Health, Addictions and Biomarkers in High Athletes Performance
Not yet recruiting NCT03280966 - Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder Phase 2
Active, not recruiting NCT01743092 - Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment N/A
Active, not recruiting NCT01528982 - Susceptibility to Pathological Gambling N/A
Terminated NCT00211822 - Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD) N/A
Completed NCT01381250 - Effects of Internet-based Treatment of Pathological Gambling N/A
Completed NCT05506384 - Treatment Study for Problematic Gaming and Gambling N/A
Terminated NCT01560351 - Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study N/A
Completed NCT00580567 - Impulsivity in Pathological Gambling N/A
Completed NCT02240485 - Integrative Couple Treatment for Pathological Gambling N/A
Withdrawn NCT01340274 - Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling Phase 2
Recruiting NCT02491996 - The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers N/A
Recruiting NCT01154712 - Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling Phase 1
Completed NCT00927563 - Tolcapone Treatment of Pathological Gambling Phase 2
Completed NCT01843699 - Topiramate Trial for Pathological Gamblers Phase 2